Naphat Chantaravisoot

850 total citations
29 papers, 465 citations indexed

About

Naphat Chantaravisoot is a scholar working on Molecular Biology, Infectious Diseases and Cell Biology. According to data from OpenAlex, Naphat Chantaravisoot has authored 29 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Cell Biology. Recurrent topics in Naphat Chantaravisoot's work include CRISPR and Genetic Engineering (6 papers), SARS-CoV-2 detection and testing (5 papers) and Microtubule and mitosis dynamics (4 papers). Naphat Chantaravisoot is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), SARS-CoV-2 detection and testing (5 papers) and Microtubule and mitosis dynamics (4 papers). Naphat Chantaravisoot collaborates with scholars based in Thailand, United States and Japan. Naphat Chantaravisoot's co-authors include Fuyuhiko Tamanoi, Piriya Wongkongkathep, Molly Hardt, Sunchai Payungporn, Trairak Pisitkun, Pattaraporn Nimsamer, Joseph A. Loo, Paul S. Mischel, Yong Poovorawan and Jiratchaya Puenpa and has published in prestigious journals such as Cancer Research, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Naphat Chantaravisoot

26 papers receiving 459 citations

Peers

Countries citing papers authored by Naphat Chantaravisoot

Since Specialization

Citations

This map shows the geographic impact of Naphat Chantaravisoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naphat Chantaravisoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naphat Chantaravisoot more than expected).

Fields of papers citing papers by Naphat Chantaravisoot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naphat Chantaravisoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naphat Chantaravisoot. The network helps show where Naphat Chantaravisoot may publish in the future.

Co-authorship network of co-authors of Naphat Chantaravisoot

This figure shows the co-authorship network connecting the top 25 collaborators of Naphat Chantaravisoot. A scholar is included among the top collaborators of Naphat Chantaravisoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naphat Chantaravisoot. Naphat Chantaravisoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting glioblastoma multiforme cells with pharmacological ascorbate: Disrupting DNA damage response and mTOR cascades via extracellular H2O2 2025 ·Free Radical Biology and Medicine ·Naphat Chantaravisoot, (unknown), Onsurang Wattanathamsan, (unknown), (unknown), (unknown), (unknown), Claudia R. Oliva, Corinne E. Griguer, Visarut Buranasudja	0
2	Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage 2023 ·Antioxidants ·(unknown), Naphat Chantaravisoot, (unknown), (unknown), Onsurang Wattanathamsan, (unknown), Pithi Chanvorachote, Visarut Buranasudja	7
3	Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis 2023 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·(unknown), (unknown), Naphat Chantaravisoot, Pisit Tangkijvanich, Chaiyaboot Ariyachet	10
4	CAMSAP3 negatively regulates lung cancer cell invasion and angiogenesis through nucleolin/HIF-1α mRNA complex stabilization 2023 ·Life Sciences ·(unknown), Soichiro Sasaki, Onsurang Wattanathamsan, (unknown), (unknown), (unknown), (unknown), (unknown), Naphat Chantaravisoot, Piriya Wongkongkathep, Yoshihiro Hayakawa, Varisa Pongrakhananon	7
5	Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction 2023 ·Journal of Biomedical Science ·Onsurang Wattanathamsan, Naphat Chantaravisoot, Piriya Wongkongkathep, (unknown), (unknown), Pithi Chanvorachote, Chanida Vinayanuwattikun, Varisa Pongrakhananon	20
6	Optimal stabilization for long-term storage of nucleic acid-based CRISPR/Cas12a assay for SARS-CoV-2 detection 2023 ·Karbala International Journal of Modern Science ·Chonticha Saisawang, (unknown), (unknown), Albert J. Ketterman, Soontorn Tuntithavornwat, Pattaraporn Nimsamer, (unknown), Naphat Chantaravisoot, Trairak Pisitkun, Sunchai Payungporn	4
7	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin 2023 ·Scientific Reports ·Naphat Chantaravisoot, Piriya Wongkongkathep, (unknown), (unknown), Pornchai Kaewsapsak, Chaiyaboot Ariyachet, Joseph A. Loo, Fuyuhiko Tamanoi, Trairak Pisitkun	8
8	COVID-19 active case findings based on self-collected saliva samples with CRISPR-Cas12a detection 2022 ·Experimental Biology and Medicine ·Naphat Chantaravisoot, Pornchai Kaewsapsak, (unknown), Pattaraporn Nimsamer, (unknown), (unknown), (unknown), (unknown), Piriya Wongkongkathep, Sombat Treeprasertsuk, Sunchai Payungporn	2
9	cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus 2022 ·Frontiers in Immunology ·(unknown), Arthid Thim-uam, (unknown), Asada Leelahavanichkul, (unknown), Naphat Chantaravisoot, Trairak Pisitkun, Prapaporn Pisitkun	14
10	IRF7 -deficient MDCK cell based on CRISPR/Cas9 technology for enhancing influenza virus replication and improving vaccine production 2022 ·PeerJ ·(unknown), (unknown), (unknown), Kritsada Khongnomnan, (unknown), (unknown), (unknown), Naphat Chantaravisoot, Sunchai Payungporn	10
11	In Silico Evaluation of CRISPR-Based Assays for Effective Detection of SARS-CoV-2 2022 ·Pathogens ·Pornchai Kaewsapsak, Naphat Chantaravisoot, Pattaraporn Nimsamer, (unknown), (unknown), Sunchai Payungporn	2
12	MicroRNA-223 Suppresses Human Hepatic Stellate Cell Activation Partly via Regulating the Actin Cytoskeleton and Alleviates Fibrosis in Organoid Models of Liver Injury 2022 ·International Journal of Molecular Sciences ·Chaiyaboot Ariyachet, (unknown), Pornchai Kaewsapsak, Naphat Chantaravisoot, Depicha Jindatip, Saranyapin Potikanond, Pisit Tangkijvanich	13
13	Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimens 2021 ·Journal of Virological Methods ·Pattaraporn Nimsamer, (unknown), (unknown), Naphat Chantaravisoot, (unknown), Jiratchaya Puenpa, Yong Poovorawan, Sunchai Payungporn	19
14	Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand 2021 ·Scientific Reports ·(unknown), Dhammika Leshan Wannigama, Sirirat Luk-in, Parichart Hongsing, Cameron Hurst, Vishnu Nayak Badavath, Piroon Jenjaroenpun, Thidathip Wongsurawat, (unknown), Stephen J. Kerr, Shuichi Abe, Phatthranit Phattharapornjaroen, (unknown), Thammakorn Saethang, Naphat Chantaravisoot, Mohan Amarasiri, Paul G. Higgins, Tanittha Chatsuwan	25
15	Detection of severe acute respiratory syndrome coronavirus 2 and influenza viruses based on CRISPR-Cas12a 2020 ·Experimental Biology and Medicine ·(unknown), Pattaraporn Nimsamer, (unknown), Naphat Chantaravisoot, Kritsada Khongnomnan, Jira Chansaenroj, Jiratchaya Puenpa, Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Yong Poovorawan, Sunchai Payungporn	62
16	STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation 2020 ·iScience ·Arthid Thim-uam, Thaneas Prabakaran, (unknown), (unknown), Piriya Wongkongkathep, Naphat Chantaravisoot, (unknown), Asada Leelahavanichkul, Thitima Benjachat, Søren R. Paludan, Trairak Pisitkun, Prapaporn Pisitkun	62
17	Abstract 4535: The mTOR complex 2 promotes glioblastoma migration via the interactions with multiple actin-binding and microtubule-associated proteins 2019 ·Cancer Research ·Naphat Chantaravisoot, Piriya Wongkongkathep, (unknown), Fuyuhiko Tamanoi, Joseph A. Loo, Trairak Pisitkun	1
18	52 Difference of Seminal Plasma Proteins in Good- and Poor-Freezability Boar Ejaculates 2017 ·Reproduction Fertility and Development ·(unknown), Junpen Suwimonteerabutr, (unknown), Kakanang Buranaamnuay, Naphat Chantaravisoot, Trairak Pisitkun, Padet Tummaruk	1
19	Significance of filamin A in mTORC2 function in glioblastoma 2015 ·Molecular Cancer ·Naphat Chantaravisoot, Piriya Wongkongkathep, Joseph A. Loo, Paul S. Mischel, Fuyuhiko Tamanoi	51
20	Activating mutations of TOR (target of rapamycin) 2011 ·Genes to Cells ·Molly Hardt, Naphat Chantaravisoot, Fuyuhiko Tamanoi	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact